IRD
Opus Genetics, Inc.
5.10$
+6.1%
vs. previous close
Closing price · As of: Sep 28, 2026
Statements
Cash Flow
Opus Genetics, Inc. (IRD) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Operating Cash Flow" came in at -12 million USD. Tick rows to compare them in a chart.
All figures in millions of USD.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -3.0 | 4.5 | -5.7 | -7.3 | -5.1 | -7.4 | -9.0 | -10 | -6.2 | -9.8 | -13 | -12 | -41 | |
| 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.1 | |
| 0.6 | 0.7 | 1.0 | 0.8 | 0.8 | 0.8 | 0.9 | 0.9 | 0.8 | 0.8 | 1.5 | 1.4 | 4.5 | |
| -10 | 8.7 | 0.4 | -0.3 | 1.6 | 1.4 | -0.3 | -2.8 | 0.9 | 0.1 | -0.1 | 1.0 | 1.8 | |
| 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| – | – | – | – | – | 1.2 | – | – | – | – | – | – | – | |
| 0.0 | – | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.4 | 5.2 | -0.1 | 0.0 | 0.0 | 5.1 | |
| 5.4 | 3.6 | 2.4 | 1.5 | 0.4 | -0.1 | 20 | 0.9 | 4.5 | 24 | 28 | 41 | 97 | |
| 2.4 | 8.2 | -3.3 | -5.8 | -4.8 | -6.3 | 11 | -9.4 | -1.6 | 14 | 15 | 29 | 56 | |
| -3.0 | 4.5 | -5.7 | -7.3 | -5.1 | -7.4 | -9.0 | -10 | -6.2 | -9.8 | -13 | -12 | -41 |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: September 28, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.